Liminal BioSciences Shares Outstanding 2015-2021 | LMNL

Liminal BioSciences shares outstanding from 2015 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Liminal BioSciences Annual Shares Outstanding
(Millions of Shares)
2020 24
2019 16
2018 1
2017 1
2016 1
2015 1
2014 1
Liminal BioSciences Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 30
2021-03-31 30
2020-12-31 24
2020-09-30 24
2020-06-30 23
2020-03-31 23
2019-12-31 16
2019-09-30 23
2019-06-30 16
2019-03-31 1
2018-12-31 1
2018-09-30 1
2018-06-30 1
2018-03-31 1
2017-12-31 1
2017-09-30 1
2017-06-30 1
2017-03-31 1
2016-12-31 1
2016-09-30 1
2016-06-30 1
2016-03-31 1
2015-12-31 1
2015-09-30 1
2015-06-30 1
2015-03-31 1
2014-12-31 1
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.076B $0.002B
Liminal BioSciences Inc. is a biotechnology company. It engages in discovering, developing and commercializing novel small molecule compounds for respiratory, liver and renal diseases. The company's product pipeline consists of PBI-4050, which are in clinical stage. Liminal BioSciences Inc., formerly known as Prometic Life Sciences Inc., is based in Laval, Canada.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29